2023
Reply Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication
Altin S, Curtis J. Reply Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication. JACC Cardiovascular Interventions 2023, 16: 2336. PMID: 37758390, DOI: 10.1016/j.jcin.2023.08.027.Peer-Reviewed Original ResearchLong-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication
Altin S, Parise H, Hess C, Rosenthal N, Creager M, Aronow H, Curtis J. Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication. JACC Cardiovascular Interventions 2023, 16: 1668-1678. PMID: 37438035, DOI: 10.1016/j.jcin.2023.05.001.Peer-Reviewed Original ResearchMeSH KeywordsFemoral ArteryHumansIntermittent ClaudicationLower ExtremityPopliteal ArteryTreatment OutcomeConceptsPeripheral vascular interventionsIndex limb amputationAmputation rateIntermittent claudicationMajor amputationRevascularization ratesVascular interventionsCox proportional hazards regressionLong-term patient outcomesMajor amputation rateProportional hazards regressionKaplan-Meier estimatesFurther risk factorsLimb amputation rateClinical trial dataIndex limbIC patientsSecondary outcomesPrimary outcomeHazards regressionRisk factorsPatient outcomesLimb amputationHealthcare databasesPatients
2022
Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analysis
Ahsan M, Ahmad S, Latif A, Lateef N, Ahsan M, Abusnina W, Nathan S, Altin S, Kolte D, Messenger J, Tannenbaum M, Goldsweig A. Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analysis. European Heart Journal - Quality Of Care And Clinical Outcomes 2022, 8: 640-650. PMID: 35460230, PMCID: PMC9442849, DOI: 10.1093/ehjqcco/qcac018.Peer-Reviewed Original ResearchConceptsST-elevation myocardial infarctionPercutaneous coronary interventionAccess site bleedingCardiogenic shockTransfemoral accessTransradial accessTIMI3 flowSite bleedingCoronary interventionProcedural successContrast volumeYear mortalityMyocardial infarctionRisk ratioSystematic reviewProcedural success rateConfidence intervalsCoronary flow gradeRandom-effects modelFlow gradeTransfemoral approachRetrospective studyLower mortalityBleedingMortality
2018
Making sense of endovascular therapies for femoropopliteal disease
Altin S, Abbott J. Making sense of endovascular therapies for femoropopliteal disease. Catheterization And Cardiovascular Interventions 2018, 91: 1329-1330. PMID: 29894589, DOI: 10.1002/ccd.27651.Peer-Reviewed Original ResearchConceptsTarget lesion revascularizationSubgroup of patientsRisk of restenosisLesion revascularizationEndovascular strategiesFemoropopliteal diseaseEndovascular therapyRevascularization approachEndovascular interventionLower riskSupport drugsLesion typeWarrants investigationBiomechanical forcesCommon targetRiskRevascularizationPatientsArteryRestenosisTherapyDisease